Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06463613 · ClinicalTrials.gov registry record · NA
Using a Novel Skin Tag Removal Device
A NA study of Achrochordon, sponsored by UK Innovations GP.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06463613: Active NA study of Achrochordon, sponsored by UK Innovations GP.
NCT06463613 is a NA study of Achrochordon that is active but no longer recruiting, run by UK Innovations GP. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06463613, a NA study of Achrochordon, is active but no longer recruiting, sponsored by UK Innovations GP.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to investigate the use of a mechanical device to remove skin tags in adults. The device ("Skin Tag Removal", or STR) utilizes the ligation method by applying a silicone band around the base of a skin tag, therefore restricting the blood supply, which is vital to its growth and survival. Because this method does not include freezing or burning of tissue in or around the skin tag, it could be considered less invasive and less risky than other options.
Primary Outcome
Number of successful removals of treated acrochordons using the STR device
Conditions Studied
Interventions
- DEVICE STR Skin Tag Removal device with diary and follow-up
Study Locations (1)
California
- Center for Dermatology Clinical Research, Inc. - Fremont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2026-01-07 |
| Phase | NA |
What the registry record for NCT06463613 still lists
NCT06463613 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Achrochordon appearing as the primary indexed condition, and to 1 intervention - of which STR Skin Tag Removal device with diary and follow-up is the first listed.
NCT06463613 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06463613 about?
NCT06463613 is a clinical study titled "Using a Novel Skin Tag Removal Device". The aim of this study is to investigate the use of a mechanical device to remove skin tags in adults. The device ("Skin Tag Removal", or STR) utilizes the ligation method by applying a silicone band around the base of a skin tag, therefore restricting the blood supply, which is vital to its growth ...
What is the current status of trial NCT06463613?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-06-03. Estimated completion is 2026-01-07.
What conditions does trial NCT06463613 study?
This clinical trial studies the following conditions: Achrochordon.
What interventions are being tested in trial NCT06463613?
The interventions under investigation include: STR Skin Tag Removal device with diary and follow-up (DEVICE).
Who is sponsoring clinical trial NCT06463613?
This trial is sponsored by UK Innovations GP, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06463613 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06463613's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI